Sponsors

Non-tuberculous mycobacterial pulmonary disease

The latest data on non-tuberculous mycobacteria (NTM) was presented at this year’s virtual European Respiratory Society Congress, during which some 33,000 delegates logged on to the Congress platform.

Key areas covered in this report include the unmet need in NTM management, the challenges around NTM treatment, and diagnostic and prognostic markers.

 Non-tuberculous mycobacterial lung disease is a rare but growing problem, with an almost 10-fold increase in infections since 1995.

These infections can be chronic and progressive and patients with pre-existing lung conditions such as COPD and bronchiectasis are at higher risk of infection. This means they can often go hidden and are very challenging to treat, requiring prolonged treatment using complex multi-antibiotic regimens, often culminating in high morbidity/mortality and financial burden.

Increasing awareness of NTM among healthcare professionals will help to improve diagnosis and disease management.

A meeting report PDF is attached.

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026